FDA advisers are slated to meet in early May to discuss whether the agency should approve an OTC oral contraceptive.

A new study published in JAMA Psychiatry on March 29, 2023, shows that the wider availability of opioid use disorder (OUD)–related telehealth services and medications during the COVID-19 pandemic led to a reduced likelihood of fatal drug overdoses among Medicare beneficiaries.

New CDC data reveal that U.S. tuberculosis (TB) cases totaled 8,300 last year, an increase of 5%. CDC is urging communities at greater risk and health care providers to “Think. Test. Treat TB.”

A new study in JAMA Pediatrics published March 20, 2023, suggests that pulse oximetry overestimated arterial oxygen saturation in Black children.

An FDA advisory panel backed the use of Pfizer’s nirmatrelvir/ritonavir antiviral (Paxlovid) as a treatment for adults with COVID-19 who are at high risk for severe illness. The endorsement is expected to allow the drug, which is available under an EUA, to receive full FDA approval.